There are many problems with patents in drug development as well, as Derek Lowe discusses in these essays, http://pipeline.corante.com/archives/patents_and_ip/

There are many problems with patents in drug development as well, as Derek Lowe discusses in these essays, http://pipeline.corante.com/archives/patents_and_ip/ http://pipeline.corante.com/archives/patents_and_ip/ . It may be time to try to develop something new, maybe based on patent law, maybe not, even for pharma. ADDED: One problem pharma shares with software is "patent thickets" where there are many applicable patents, applying to different layers of technology, that the current development relies on.